Dose heterogeneity from radiopharmaceutical therapy enhances the anti-tumor immune response
Maya Takashima
Advisor: Zach Morris, MD, PhD
Characterizing EBV-positive DLBCL: patient tumors and model cell lines
Quincy Rosemarie, PhD
Johannsen Lab
6571 WIMR II
@ 3:30 pm - 4:30 pm
Dose heterogeneity from radiopharmaceutical therapy enhances the anti-tumor immune response
Maya Takashima
Advisor: Zach Morris, MD, PhD
Characterizing EBV-positive DLBCL: patient tumors and model cell lines
Quincy Rosemarie, PhD
Johannsen Lab